Literature DB >> 2396352

Effects of papaverine on human isolated bladder muscle.

L Hertle1, H Nawrath.   

Abstract

Papaverine is a non-specific smooth muscle relaxant and is thought to act at a site beyond the receptor sites on the cell membrane. In this study the relaxing properties of papaverine were tested in isolated muscle strips from the human bladder dome. In carbachol-induced contractions papaverine, even in high concentrations of 10(-4) mol/l had virtually no effects on peak tension generation, whereas the fading was accelerated and the steady state tension at 30 min. was reduced by about 54%. In contrast, high potassium-induced contractions were relaxed by papaverine in a concentration-dependent way; a concentration of papaverine of 10(-4) mol/l produced full relaxation. These findings might possibly be explained if it is assumed that papaverine blocks calcium ion channels in the cell membrane. However, the observation that rather high concentrations of papaverine were necessary to fully relax high potassium contractions and the fact, that papaverine affects cellular cAMP levels separate this drug from more selective calcium channel blockers. The calcium movements responsible for the peak tension generation in carbachol-induced contractions are obviously not affected by papaverine. Although papaverine had little effect on carbachol-induced contractions in vitro it cannot be excluded that the drug is effective in diseases were non-cholinergic mechanisms are involved.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2396352     DOI: 10.1007/bf00295853

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  13 in total

Review 1.  Mechanisms of action of transmitters and other substances on smooth muscle.

Authors:  T B Bolton
Journal:  Physiol Rev       Date:  1979-07       Impact factor: 37.312

2.  Comparison of calcium antagonist properties of antispasmotic agents.

Authors:  S B Malkowicz; A J Wein; M R Ruggieri; R M Levin
Journal:  J Urol       Date:  1987-09       Impact factor: 7.450

3.  Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs.

Authors:  W R Kukovetz; G Pöch
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

4.  [Influence of cardio- and vasoactive substances on phosphodiesterase activity].

Authors:  G Pöch; H Juan; W R Kukovetz
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

5.  [Effect of beta-receptor blocking agents and related substances on the excitation, contraction and energy metabolism of myocardium fibers].

Authors:  A Fleckenstein; H J Döring; H Kammermeier
Journal:  Klin Wochenschr       Date:  1968-04-01

6.  [Electromechanical uncoupling on the uterine muscle by "musculotropic" relaxants].

Authors:  G Grün; A Fleckenstein; H Tritthart
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

7.  Intracavernous injection of papaverine for erectile failure.

Authors:  R Virag
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321

8.  Effects of nifedipine on the smooth muscle of the human urinary tract in vitro and in vivo.

Authors:  A Forman; K E Andersson; L Henriksson; T Rud; U Ulmsten
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-08

9.  Mechanisms behind the biphasic contractile response to potassium depolarization in isolated rat cerebral arteries.

Authors:  E D Högestätt; K E Andersson
Journal:  J Pharmacol Exp Ther       Date:  1984-01       Impact factor: 4.030

10.  Receptor operated intracellular calcium stores in the smooth muscle of the guinea pig bladder.

Authors:  J L Mostwin
Journal:  J Urol       Date:  1985-05       Impact factor: 7.450

View more
  3 in total

1.  Effects of papaverine on tension and 45Ca-uptake in isolated urinary bladder.

Authors:  W Diederichs
Journal:  Urol Res       Date:  1991

2.  Papaverine reduces the sodium permeability of the apical membrane and the potassium permeability of the basolateral membrane in isolated frog skin.

Authors:  H Andersen; R Nielsen
Journal:  J Membr Biol       Date:  1992-03       Impact factor: 1.843

Review 3.  The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.

Authors:  Philippa R Dale; Hana Cernecka; Martina Schmidt; Mark R Dowling; Steven J Charlton; Michael P Pieper; Martin C Michel
Journal:  Curr Opin Pharmacol       Date:  2014-03-27       Impact factor: 5.547

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.